Related Experiment Video
Updated: Jul 2, 2026

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
Acute oxygen therapy does not improve cognitive and driving performance in hypoxaemic COPD
Jeffrey J Pretto1, Christine F McDonald
1Department of Respiratory and Sleep Medicine, Institute for Breathing and Sleep, Austin Hospital, Heidelberg, Victoria, Australia.
Supplemental oxygen therapy does not improve simulated driving performance or cognitive function in patients with hypoxaemic chronic obstructive pulmonary disease (COPD). These findings do not support oxygen use while driving for this population.
Area of Science:
- Respiratory Medicine
- Neurology
- Transportation Safety
Background:
- Hypoxaemia in Chronic Obstructive Pulmonary Disease (COPD) can impair cognitive and neuropsychological function.
- Previous studies have demonstrated adverse effects of low blood oxygen levels on cognitive function in hypoxaemic COPD patients.
Purpose of the Study:
- To assess the justification of supplemental oxygen therapy for driving in hypoxaemic COPD patients.
- To investigate if acute intranasal oxygen therapy improves cognitive and driving performance using computer-based simulation.
Main Methods:
- A randomized, double-blind, cross-over study involving 30 hypoxaemic COPD patients with driving licenses.
- Participants completed a 20-minute driving simulation and a 10-minute psychomotor vigilance task (PVT) under two conditions: breathing supplemental intranasal oxygen versus room air.
- Data were collected at baseline and during the randomized conditions.
Main Results:
- No statistically significant differences were observed in driving performance measures between oxygen and air conditions.
- Reaction times in the psychomotor vigilance task (PVT) showed no significant improvement with oxygen therapy.
- Mean age of participants was 72 years, with a mean driving experience of 50 years.
Conclusions:
- Acute oxygen therapy does not enhance simulated driving performance or neurocognitive function (assessed by PVT) in hypoxaemic COPD patients.
- Current data do not support recommending oxygen use for driving in this patient group.
- Further research may be needed to explore other interventions for driving safety in hypoxaemic COPD.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Oxygen Transport in the Blood
COPD: Management Using Bronchodilators and Corticosteroids
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
